study. In this prospective randomized cross over study, 40 consecutive patients suffering from medically intractable epilepsy evaluated by single neurologist (MT) scheduled to undergo surgical resection of epileptogenic foci with the use of ECoG guidance under general anesthesia by single neurosurgeon (PSC) between March 2008 and December 2010 were enrolled. All included patients had well defined lesion on MRI (hippocampal sclerosis, either focal cortical dysplasia, tumor or gliosis) with defined concordance on inter ictal EEG (electroencephalography), Video EEG, SPECT (single photon emission tomography) and PET (positron emission tomography). Cases of hippocampal sclerosis have also been included as it does come under the definition of a 'lesion' and recordings could easily be performed using a strip electrode placed over it longitudinally. The size of the grid chosen was always larger than the size of the lesion. Exclusion criteria were patients with doubtful concordance or with a more diffuse surgical substrate, patients with morbid obesity, pregnancy and known allergy to the anesthetic drugs used. Pre-anesthetic evaluation included relevant clinical history, complete general and neurological examination. All the cases were discussed for possible role of surgery in the epilepsy surgery case conference and underwent standard workup for medically intractable epilepsy including inter-ictal EEG, VEEG, MRI (magnetic resonance imaging), SPECT, PET, subtraction ictal SPECT co-registered to MRI. Preoperatively, all patients were kept fasting according to the standard guidelines and received antisialogogue premedication (40 m/kg intramuscular glycopyrrolate in adults or 20 m/kg oral atropine in pediatric patients) before being shifted to the operation theater. Patients continued to take all antiepileptic drugs till the morning of surgery (Table 1) . No sedative premedication was given. Inside the operation theater, monitoring with 5-lead electrocardiography (ECG), non-invasive blood pressure (NIBP), pulse oximetry and bispectral index (BIS) (Aspect Medical System, A-2000, USA) was performed. BIS is a numerical index ranges from 100 (awake) to 0 (isoelectric EEG). BIS values of 40-60 reflect adequate hypnotic effect for general anesthesia with reasonably rapid recovery to consciousness. In adults and co-operative patients, general anesthesia was induced with fentanyl 2 mg/kg and thiopentone 3-5 mg/kg, whereas in small children and uncooperative patients inhalational induction was done using sevoflurane in oxygen. Tracheal intubation was facilitated by rocuronium 1 mg/kg and all patients were mechanically ventilated to maintain end tidal carbon dioxide of 35 AE 2 mm Hg. Anesthesia was maintained with either isoflurane (Group 'Isoflurane') or propofol infusion (Group 'Propofol') as per a computer generated randomization charts. In both the groups the study was divided in two stages (Fig. 1 ). In the first stage either air or nitrous oxide (N 2 O) was used in the inhalation gas mixture (FiO 2 0.5) according to randomization. All patients received infusion of fentanyl 1 mg/kg/h and rocuronium 0.5 mg/kg/h for intra-operative analgesia and muscle relaxation respectively. Anesthetic depth was maintained by keeping BIS in range of 50 AE 5 (normal range 40-60). All patients received normal saline or ringers lactate as intraoperative fluid. Normothermia (nasopharyngeal temperature 36-37 8C) was maintained using a forced air warming blanket. A wide craniotomy was performed and after dural reflection a large ECoG grid was placed over the surface of the brain. Once satisfactory ECoG was obtained with carrier gas under study (at least for 20 min duration), the first gas was turned off and second gas (either N 2 O or air) was started marking the second stage of the study (for another 20 min). In order to eliminate the carry over effect of the gas under study a washout period of 20 min was allowed or till the expired gas concentration turned to zero for the gas under study, before starting the second carrier gas. ECoG was analyzed and graded by a blinded neurologist using the grading system described by Marthen et al. 7 This scoring was developed for cortical dysplasia, however this is the only objective scoring available so we used it to define objectively the ECoG findings irrespective of the underlying pathology.
The ECoG scoring system is briefly described below:
ECoG Score 0: Normal activity. ECoG Score 1: Normal background of mixed gamma, beta and alpha frequencies of moderate to low amplitude (i.e., usually < 20-30 mV). A few low-amplitude spikes could be observed. ECoG Score 2: Loss of fast (>20 Hz) background frequencies, but otherwise a background of mixed alpha, beta and delta frequencies of low to moderate amplitude. Repeated but non-continuous, spikes, polyspikes or paroxysmal fast activity of medium amplitude often observed. ECoG Score 3: Mostly 6-20 Hz background frequencies with some localized nearly continuous interictal epileptiform features of moderate amplitude or persistent repetitive spiking. Very rarely, electrographic seizures can be captured. ECoG Score 4: Slow (<6 Hz) background frequencies with continuous synchronous features of moderate to high amplitude. Multiple independent epileptiform abnormalities (polyspikes, paroxysmal fast activity and electrographic seizures) could be recorded. ECoG Score 5: Slow rhythmic usually synchronous background (<4 Hz), often of high amplitude. Continuous synchronized or independent high-amplitude epileptiform abnormalities in multiple cortical sites could be observed. Ictal discharges are rarely recorded but observed in surrounding cortex.
As per this reference of ECoG scoring, score zero would mean no spikes, or sharps, high amplitude discharges, etc. Only a background rhythm ranging from beta to delta low amplitudehigh grades (4 or 5) are defined as multifocal discharges within the grid domain and not the whole brain. An ECoG score of 2-5 was considered abnormal.
ECoG recordings were performed using 64 channel machine (Nicolet, Viasys, USA). The reference electrode was placed over the forehead and the recordings were performed by both reference and bipolar derivations. Recordings from neocortical structures were performed using a large grid (32 contacts) to cover the entire area representing the lesion and the perilesional area. The recording from the hippocampus (in mesial temporal sclerosis) was done after performing anterolateral temporal lobectomy, followed by placement of strip (1 Â 4) over the mesial temporal lobe and hippocampus and ECoG guided amygdalohippocampectomy. 8 Anterolateral temporal lobectomy is the standard procedure performed by our surgeon (PSC) and not selective amygdalohippocampectomy as most of the cases we see have long standing epilepsy (average 8-9 years) by which time we frequently notice reactive changes (e.g. signal changes, gliosis atrophy, etc.) within the parahippocampus and even the lateral temporal structures.
Low frequency filter was set at 1 Hz and high frequency filter was set at 70 Hz and sensitivity was set between 300 and 5000 mV/ mm depending upon the amplitude of background and discharges. Heart rate (HR), mean arterial pressure (MAP), oxygen saturation (S P O 2 ), end-tidal carbon dioxide (E T CO 2 ), inspired fraction of volatile anesthetic agent (FiAA) were constantly measured. HR and MAP were maintained within 20% of baseline values. Rocuronium and fentanyl infusion were stopped at the completion of dural closure. Anesthetic agent under study was stopped at start of skin closure. After application of dressing, N 2 O if in use was discontinued. Time taken for the procedure and total duration of anesthesia were recorded. Neuromuscular blockade was reversed with neostigmine (50-70 mg/kg) and glycopyrrolate (08-10 mg/kg). Tracheal tube was removed only when the patient started obeying simple commands and his/her vital parameters were satisfactory. Emergence time (time from turning off N 2 O to the time when patient starts obeying simple commands) and extubation time (time from turning off N 2 O to removal of tracheal tube) were noted. Thereafter, all patients were shifted to neurosurgical intensive care unit for observation and further management. After discharge from the hospital, patients were followed up telephonically and in the neurosurgery outpatient department. At 6-24 months after the discharge, seizure control was graded using Engel's criteria.
Statistical analysis
All the data were analyzed using STATA 9.0 and are presented as mean (SD) or number (%). Fisher's exact test and Chi square test were used for categorical data, whereas, numerical data were analyzed using two sample 't' test with equal variance. Analysis of variance (ANOVA) test for 2 Â 2 cross over study was used to assess the carry over effect (presence of the effect of the first treatment at the time of evaluation of next treatment), treatment effect (effect of treatment on primary outcome) and period effect (the tendency of the patient groups to either improve or deteriorate over time). The value of p less than 0.05 was considered significant.
Results
A total of 40 patients were enrolled in the study and were equally divided into isoflurane and propofol groups according to computerized randomization. One patient in the isoflurane group was excluded because of inability to obtain ECoG recording due to a technical problem. The individual profiles of all the patients in both the groups are shown in In the isoflurane group (n = 19), 08 patients had temporal lobe epilepsy and 11 patients had extratemporal epilepsy whereas in the propofol group (n = 20), the numbers were 11 and 9 respectively (Table 1) . Preoperative and intraoperative trends of HR, MAP and BIS score were comparable in both the groups.
ECoG recordings
ECoG could be recorded in all the patients except for one patient in the isoflurane group (due to technical reasons), and was excluded in the final analysis. All patients were operated by single neurosurgeon (PSC) and the ECoG recordings were evaluated by a single neurologist (MT) who was blinded to the anesthetic technique. The recordings were analyzed using scoring system described by Marthen et al. 7 The ECoG grading has been provided in such a manner so the grade I is normal and grade V is most abnormal. Thus shifting to a higher grade in the same patient with a change of anesthetic agent was considered as the agent having a better capability of detecting optimal ECoG recordings.
Isoflurane group
Mean BIS scores at the time of ECoG recordings were 49(5.7) and 46(8.8) with air and N 2 O respectively. The mean inspired concentration of isoflurane during ECoG recordings were 0.8(0.4) and 0.7(0.2) with air and N 2 O respectively. Mean ECoG score with N 2 O (3.0) was lower than the mean ECoG score with air (3.9) (p 0.01) ( Fig. 2A and B) , irrespective of the order of randomization of the two gases (Table 2 ). There was no difference between the two treatment periods (air/N 2 O) (p = 0.6). There was no carry over effect (treatment Â period) between the two periods (p = 0.2). The carryover effect occurs when two treatment conditions are applied to the same participant, and the effect of the first treatment ''carries over'' to the second.
Propofol group
The mean BIS scores at the time of ECoG recordings were 50(9.5) and 48(11.3) with air and N 2 O respectively. The mean ECoG scores with N 2 O (3.2) was lower than the mean ECoG with air (3.4) (Fig. 2C and D) , though the difference was not statistically significant (p = 0.5) ( Table 2) . No difference was observed between two periods (air or N 2 O) (p = 0.6). There was no carry over effect between the two periods (p = 0.2) ( Table 2) .
The mean ECoG scores in the two groups were analyzed using two sample 't' test with equal variance. The mean ECoG scores were comparable in the two groups as shown in Table 3 .
The perioperative outcome
In isoflurane and propofol group the mean duration of anesthesia (h), surgery (h), emergence time (min), extubation time (min), ICU stay and hospital stay (days) were 6.1(1.2) [3] [4] [5] [6] [7] [8] 
Follow up data
Follow up duration was 3-24 months (median = 14 months) after discharge from the hospital. Twelve out of 19 (63.2%) patients in isoflurane group had good outcome (10, Engel class I and 2, Engel class II), where as 05 patients experienced worthwhile improvement in seizure control (Engel's class III). In propofol group, 12 (60.0%) out of 20 patients, had good outcome (7, Engel class I and 5, Engel class II), 02 patients had worthwhile improvement in seizure control (Engel's class III). However, 02 patients in the propofol group had no worthwhile improvement (Engel's class IV). Out of these 02, one patient underwent porencephalic cyst excision, whereas the other one was operated for mesial temporal sclerosis.
Discussion
In our study successful ECoG recordings were possible with use of BIS titrated doses of either isoflurane or propofol. Addition of nitrous oxide caused suppression of these recordings in both the groups (p 0.01 vs 0.5). Despite its limitations ECoG is widely used to demarcate epileptogenic zones. The main shortcomings of ECoG is the short duration of its recordings, its inability to seldom capture the seizures and the localization usually relying on interictal abnormal activity. These inter-ictal discharges may be false positive or false negative. Lateralization and localization is required through preoperative work up for correct placement of ECoG grid. 5 The reliability of ECoG is uncertain because relation between intraoperative and extraoperative spike frequency or the spatial pattern of spike frequency is not well documented. 9 The various anesthetic techniques may have effect on both the background activity and epileptiform discharges. 4 Both anticonvulsant as well as proconvulsant properties have been described with various anesthetic agents and at various doses. 10 The primary objective for choosing an anesthetic agent in a patient scheduled to undergo ECoG for epilepsy surgery is that it should not provoke seizure and at the same time should not interfere with recordings. Isoflurane is commonly used anesthetic during ECoG recordings.
11,12
Fiol et al. have studied the effect of isoflurane and nitrous oxide on ECoG recordings and found that isoflurane (0.25-1.25%) along with N20 (50-70%), has no effect on spike activity. 11 Asano et al., compared intraoperative and chronic invasive ECoG in 12 children with neocortical epilepsy. 12 At the time of ECoG recording, anesthesia was maintained with isoflurane (0.5-1%, FiO 2 0.5). They observed decrease in the spike frequency under general anesthesia but it reliably reflected the awake inter-ictal spiking pattern when spike frequency was >1 spike/min. Higher the number of spikes, better was the correlation between intraoperative and postoperative spike frequency pattern. Our findings were consistent with previous investigators. We found that satisfactory ECoG recordings were possible with BIS (50 AE 5) titrated doses of isoflurane (0.5-1.25%) but addition of 50% nitrous oxide decreased the ECoG scores. Propofol is a favored agent among the neuroanesthesiologists, but its use in epilepsy patients and for epilepsy surgery is debated. Though, the anticonvulsant properties of propofol are well established, many reports have also highlighted its proconvulsant effects. 13 Use of propofol has been associated with generation of beta EEG activity which obscures the underlying spike wave activity for up to 20 min after stopping its infusion, which is its major shortcoming for electrocorticographic monitoring. 14, 15 However, Samara and colleagues, reported no significant change in epileptiform activity in patients with complex partial epilepsy receiving sedative doses of propofol. 16 Similarly, Schneider and colleagues, studied the effects of propofol on electrocorticography in patients with intractable epilepsy and documented no seizure activity or decrease in the number of spikes or spike burst suppression patterns in ECoG. Treatment effect (p 0.01); period effect (p = 0.6); carry over effect (p = 0.2). Analysis of variance (ANOVA) test for 2 Â 2 cross over study was used to assess the carry over effect, treatment effect and period effect. a Numerical data were analyzed using two sample 't' test with equal variance. b The two columns represent the sequence of application of two gases (nitrous oxide followed by air and vice a versa) according to randomization. We could satisfactorily recognize spike and wave interictal activity with a BIS targeted (50 AE 5) dose of propofol. In this group too the addition of nitrous oxide to the anesthetic regimen decreased the ECoG scores but it was not statistically significant (p = 0.5). N 2 O is considered fairly inert in both development and the treatment of seizure activity in humans, however, its complex interactions have been described with other potent anesthetic agents. 10 Fentanyl has been described to possess pro-convulsant properties and it has been used to evoke seizure during epilepsy surgery. 10, 20, 21 Tempelhoff and colleagues, studied the effect of fentanyl (mean dose 25.7 mg/kg) on ECoG and found that the use of fentanyl in such doses was associated with electrographic seizures. 20 Manninen and colleagues evaluated the effectiveness of opioids (fentanyl and alfentanil) for intraoperative stimulation of epileptiform activity in patients undergoing surgery for intractable temporal lobe epilepsy. They concluded that fentanyl in a dose of 10 mg/kg can be useful for intraoperative localization of seizure focus as it induced an increase in spike activity in all patients. 21 We have used low dose fentanyl infusion (1 mg/kg/h) in both the groups, which is unlikely to result in significant interactions with ECoG recordings. BIS is widely used as a reliable monitor of anesthetic depth. BIS has been found to be reliable predictor of level of consciousness with propofol and isoflurane anesthesia. 22 However there are reports of increase in BIS score with the use of nitrous oxide. 23 There are opinions both in favor and against the use of BIS monitoring, but still it remains the most widely used monitor to titrate the depth of anesthesia. 24 Despite extensive literature search we could not find any study evaluating the effect of BIS targeted anesthetic regimens on ECoG. In this double blind, randomized cross over study, we found it to be useful monitor for titration of anesthetic agents for satisfactory ECoG recordings. Seizure control after epilepsy surgery has been reported to be variable depending upon the underlying pathology. TellezZentenol and colleagues in a meta-analysis described long term seizure control of about 66% with temporal lobe resections, 46% with occipital and parietal resections, and 27% with frontal lobe resections. 25 Engel have described a seizure control of 67.9% in patients undergoing limbic resections, 45.1% for neocortical resections, 67.4% for hemispherectomies, 45.2% for large multilobar resections, 7.6% for corpus callosotomies during 1986-1990. 26 In the present study with 39 patients having temporal and extratemporal lobe epilepsy, overall long term seizure control (Engels class I and II) was 62%, with up to 70% seizure control in patients with temporal lobe epilepsy. We do acknowledge the limitations of this study (a) use of single concentration of nitrous oxide, (b) unavailability of baseline intracranial recordings without anesthesia: an ideal study would be to compare the ECoG recordings under various anesthetic agents as well with under awake conditions as would be the case in invasive recordings. (c) Comparison of partial epilepsies irrespective of the localization and etiology (temporal lobe epilepsies/ extratemporal lobe epilepsies; neocortical epilepsies/mesial temporal lobe epilepsies; lesional/non-lesional epilepsies). There are differences in epileptogenecity depending on the localization and pathology of the epileptogenic zone. However our primary objective was to see the effect of various anesthetic agents on the amplitude and frequency of discharges noting which would bring out maximum frequency of pick up of discharges and not to note which etiology produced discharges. In our study each patient acted as his own control and was not compared with other patients with different pathology. (d) Small size of cohort. However we would like to emphasize that this is first of its kind of study and reasonably demonstrates the effect of anesthetic drugs on ECoG recordings. This study would help in developing protocols, which would be optimal in performing ECoG.
Conclusions
We studied in a double blind, randomized cross over manner, effects of different anesthetic techniques, on electrocorticography in patients undergoing epilepsy surgery and found that satisfactory recordings may be obtained with use BIS titrated doses of either isoflurane or propofol. Addition of nitrous oxide as a carrier gas reduced the ECoG scores.
